These studies suggest that Rb1 can decrease lipid accumulation by inducing the lipolysis–thermogenesis cascade [i.e. AMPKα, adipose triglyceride lipase (ATGL), and UCP1] within WAT depots, confirming its therapeutic potential for counteracting obesity [71]. Here, PNPLA2 is linked to obesity disorder.